ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...
Nearly a year ago, New York City embarked on a controversial program to toll drivers entering some of Manhattan’s busiest streets. The goal of the congestion pricing plan, the first of its kind in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback